These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 105807)

  • 1. Animal models for the comparative assessment of neurotoxicity following repeated administration of vinca alkaloids.
    Todd GC; Griffing WJ; Gibson WR; Morton DM
    Cancer Treat Rep; 1979 Jan; 63(1):35-41. PubMed ID: 105807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
    Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snail neurons as a possible model for testing neurotoxic side effects of antitumor agents: paracrystal formation by Vinca alkaloids.
    Müller LJ; Moorer-van Delft CM; Roubos EW
    Cancer Res; 1988 Dec; 48(24 Pt 1):7184-8. PubMed ID: 3191492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
    Iqbal Z; Ochs S
    J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological assessment of triphenyl phosphite neurotoxicity in the hen.
    Carrington CD; Brown HR; Abou-Donia MB
    Neurotoxicology; 1988; 9(2):223-33. PubMed ID: 3205432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamic acid modification of vincristine toxicity.
    Jackson DV; Rosenbaum DL; Carlisle LJ; Long TR; Wells HB; Spurr CL
    Cancer Biochem Biophys; 1984 Sep; 7(3):245-52. PubMed ID: 6149015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristine.
    Rivera-Fillat MP; Pallarés-Trujillo J; Domènech C; Grau-Oliete MR
    Br J Pharmacol; 1988 Apr; 93(4):902-8. PubMed ID: 3390658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs.
    Todd GC; Gibson WR; Morton DM
    J Toxicol Environ Health; 1976 May; 1(5):843-50. PubMed ID: 1271489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive interaction of bisbenzylisoquinoline alkaloid, cepharanthin, with vinca alkaloid agents against human tumors.
    Ono M; Tanaka N
    In Vivo; 1997; 11(3):233-41. PubMed ID: 9239517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
    Jackson DV; Castle MC; Poplack DG; Bender RA
    Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on axonal fibrillar organelles in vitro.
    Donoso JA; Green LS; Heller-Bettinger IE; Samson FE
    Cancer Res; 1977 May; 37(5):1401-7. PubMed ID: 558047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T; Masaoka T; Shibata H; Kubota Y; Saigo K; Kusakabe H; Takubo T; Nakamura H; Yoshitake J; Ishigami S
    Gan To Kagaku Ryoho; 1982 Feb; 9(2):306-15. PubMed ID: 6764103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxic substances.
    Le Quesne PM
    Mod Trends Neurol; 1975; 6():83-97. PubMed ID: 172775
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of vinca alkaloids.
    Rahmani R; Zhou XJ
    Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity.
    Borman LS; Bornmann WG; Kuehne ME
    Cancer Chemother Pharmacol; 1993; 31(5):343-9. PubMed ID: 8431967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinca alkaloids.
    Moudi M; Go R; Yien CY; Nazre M
    Int J Prev Med; 2013 Nov; 4(11):1231-5. PubMed ID: 24404355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetylvinblastine amide (vindesine) sulfate.
    Barnett CJ; Cullinan GJ; Gerzon K; Hoying RC; Jones WE; Newlon WM; Poore GA; Robison RL; Sweeney MJ; Todd GC; Dyke RW; Nelson RL
    J Med Chem; 1978 Jan; 21(1):88-96. PubMed ID: 412968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.